CTMX
Price
$2.65
Change
+$0.13 (+5.16%)
Updated
May 30 closing price
Capitalization
415.13M
67 days until earnings call
MLEC
Price
$7.41
Change
-$0.59 (-7.37%)
Updated
May 30, 10:30 AM (EDT)
Capitalization
32M
148 days until earnings call
Interact to see
Advertisement

CTMX vs MLEC

Header iconCTMX vs MLEC Comparison
Open Charts CTMX vs MLECBanner chart's image
CytomX Therapeutics
Price$2.65
Change+$0.13 (+5.16%)
Volume$3.91M
Capitalization415.13M
Moolec Science SA
Price$7.41
Change-$0.59 (-7.37%)
VolumeN/A
Capitalization32M
CTMX vs MLEC Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. MLEC commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a StrongBuy and MLEC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (CTMX: $2.65 vs. MLEC: $8.00)
Brand notoriety: CTMX and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 68% vs. MLEC: 4%
Market capitalization -- CTMX: $415.13M vs. MLEC: $32M
CTMX [@Biotechnology] is valued at $415.13M. MLEC’s [@Biotechnology] market capitalization is $32M. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 5 TA indicator(s) are bullish while MLEC’s TA Score has 6 bullish TA indicator(s).

  • CTMX’s TA Score: 5 bullish, 4 bearish.
  • MLEC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MLEC is a better buy in the short-term than CTMX.

Price Growth

CTMX (@Biotechnology) experienced а +18.83% price change this week, while MLEC (@Biotechnology) price change was -10.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

CTMX is expected to report earnings on Aug 07, 2025.

MLEC is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($415M) has a higher market cap than MLEC($32M). CTMX YTD gains are higher at: 157.282 vs. MLEC (0.000). CTMX has higher annual earnings (EBITDA): 26.8M vs. MLEC (-5.24M). CTMX has more cash in the bank: 101M vs. MLEC (926K). CTMX has less debt than MLEC: CTMX (9.39M) vs MLEC (22.1M). CTMX has higher revenues than MLEC: CTMX (138M) vs MLEC (7.83M).
CTMXMLECCTMX / MLEC
Capitalization415M32M1,297%
EBITDA26.8M-5.24M-511%
Gain YTD157.2820.000-
P/E Ratio5.52N/A-
Revenue138M7.83M1,762%
Total Cash101M926K10,907%
Total Debt9.39M22.1M42%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXMLEC
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
33%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 3 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 3 days ago
56%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 3 days ago
25%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 13 days ago
57%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 3 days ago
17%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHLVX51.420.08
+0.16%
JHancock Fundamental Large Cap Core C
NSEPX21.25N/A
N/A
Columbia Select Large Cap Equity Inst
GCVUX23.37-0.04
-0.17%
Goldman Sachs Large Cp Val Insghts R6
MGFSX9.94-0.02
-0.20%
MassMutual Global R5
SDMGX18.58-0.06
-0.32%
Sit Developing Markets Growth

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
+5.16%
MLEC - CTMX
42%
Loosely correlated
N/A
CRNX - CTMX
38%
Loosely correlated
-0.03%
BCAB - CTMX
37%
Loosely correlated
+4.60%
NKTR - CTMX
37%
Loosely correlated
-2.02%
VCYT - CTMX
36%
Loosely correlated
-1.30%
More

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with WINT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
N/A
WINT - MLEC
49%
Loosely correlated
-3.67%
CTMX - MLEC
42%
Loosely correlated
+5.16%
AAVXF - MLEC
38%
Loosely correlated
N/A
ABEO - MLEC
36%
Loosely correlated
+1.30%
ABVC - MLEC
31%
Poorly correlated
-2.14%
More